Navigation Links
Vapotherm Closes Financing Round, Appoints James Liken as Chairman of the Board and Opens New Corporate Headquarters
Date:4/24/2013

EXETER, N.H., April 24, 2013 /PRNewswire-USNewswire/ -- On April 12, 2013 Vapotherm closed a $29MM financing round which was led by the 3x5 Special Opportunity Fund L.P. and included new investor Morgenthaler Venture Partners L.P.  Existing investors GE Asset Management, Kaiser Permanente, Integral Capital Partners, QuestMark Partners and Cross Creek Capital also participated in the current round. The proceeds from this financing will be used to fund the Company's growth plans.

Tony Arnerich , General Partner of the 3x5 Special Opportunity Fund, and Jason Lettmann , Principal of Morgenthaler Venture Partners, both join the Board of Directors.

"We are delighted to be a part of the Vapotherm story," said Tony Arnerich , General Partner of the 3x5 Special Opportunity Fund.  "The unique technology and its clinical benefit for patients with a wide variety of breathing disorders is what appealed to our group. We look forward to supporting the Company and its management team."

James "Jim" Liken, a board member since April 2010, has agreed to serve as Chairman of the Board of Directors.  Jim has extensive experience with respiratory technology companies, including Respironics Inc. where he served as President and CEO from August 1999 through December 2003 and as Vice Chairman until March 2008.

"I have been part of the team for almost three years and am pleased to serve in this new capacity.  This is a very exciting time for Vapotherm," said Jim Liken.

Bill Niland , Founder of Vapotherm said, "We appreciate the support of new investors 3x5 and Morgenthaler and our existing investors, as well as Jim's commitment to serve as Chairman of the Board.  He brings a wealth of knowledge and experience to our organization."

In addition to closing the financing Vapotherm opened new corporate headquarters in Exeter, New Hampshire at the start of the year.  The facility, located at 22 Industrial Drive, incorporates 14,400 square feet of office space and 12,000 square feet of manufacturing space. 

"One of the key reasons for moving corporate headquarters to Exeter was to have access to the New England medtech industry, including suppliers, partners, and the deep talent pool," said Joe Army , President and CEO of Vapotherm.  "We look forward to expanding our operations in the New Hampshire seacoast region and having a positive impact in the community."

Vapotherm, Inc. is a privately held manufacturer of advanced respiratory care devices based in Exeter, New Hampshire.  The company develops innovative, comfortable, noninvasive technologies for respiratory support of patients with chronic or acute breathing disorders.  Over 500,000 patients have been treated with Vapotherm high flow therapy.  For more information, visit www.vtherm.com.

Contact:
John Landry , CFO (603) 658-0011


'/>"/>
SOURCE Vapotherm, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Aethlon Medical Discloses Cancer and Infectious Disease Therapy Presentation at ISEV 2013
2. InspireMD Closes $25 Million Underwritten Public Offering
3. Inovio Pharmaceuticals Closes $15.1 Million Offering of Common Stock and Warrants
4. PTC Therapeutics Closes $60 Million Private Financing
5. Spring Bank Pharmaceuticals Closes $10.5 million Series A Financing to fund Phase I Clinical Trials in HCV-infected Patients
6. Sphere Fluidics Successfully Closes a $2.5 million Series A Investment Round
7. Aratana Closes $12 Million Series C Financing to Fund Pipeline Expansion
8. Aethlon Medical Discloses CEO Interview
9. Wright Therapy Products, Inc. Closes $3 million Financing Round
10. Synthetic Biologics Closes Deal for Acquisition of C. difficile Infectious Disease Program
11. Edison Pharmaceuticals Closes $20M Series F Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... DUBLIN , Jan 18, 2017 Research ... Nausea and Vomiting Drugs Market 2017-2021" report to their offering. ... The global ... the period 2017-2021. Global Thoracic Surgery Market 2017-2021, ... from industry experts. The report covers the market landscape and its ...
(Date:1/18/2017)... SHANGHAI , Jan. 18, 2017 In ... of revolution, which is where the Upgrade of ... year of the 13th Five-Year Plan for Economic and Social ... (the 13th Five-Year Plan), and the state council of ... the "13th Five-Year" national strategic emerging industry development plan, identifying ...
(Date:1/18/2017)... Ximbio, a non-profit online one-stop-shop for the global ... first North American headquarters in Kendall Square, Cambridge, ... ... launch in October 2014 as a business unit of UK- ... the foundation Cancer Research UK. Ximbio.com allows scientists ...
Breaking Medicine Technology:
(Date:1/18/2017)... ... January 18, 2017 , ... Michael J. Hennessy Associates, Inc., ... Center for Biosimilars, announced Michael J. Hennessy Associates, Inc. President Michael J. Hennessy, ... biosimilars through thought leader interaction in, live video and interactive digital platforms. , ...
(Date:1/17/2017)... ... January 17, 2017 , ... January is National Stalking Awareness Month (NSAM), now ... in the corners and commit the crime of stalking, a very real danger to many ... often overlooked factor in stalking and other crimes. , “Stalking: know it. Name it. Stop ...
(Date:1/17/2017)... ... 17, 2017 , ... Today, to help those who are ... uplifting interview with medical expert and prolific author, Dr. Bernie Siegel. ... times, Dr. Bernie Siegel energizes listeners to live life with intrigue, magic and ...
(Date:1/17/2017)... (PRWEB) , ... January 17, 2017 , ... ... a new 21st century approach to infusing high speed technology into the fabric ... exclusively dedicated to the advancement of healthcare and wellness in a yet-to-be-named, health ...
(Date:1/17/2017)... ... January 17, 2017 , ... ... will lecture to primary eye care practitioners on the latest breakthroughs in the ... 13th Semi-Annual Continuing Education Symposium, according to eye surgeon, Jeffrey Martin, MD, FACS, ...
Breaking Medicine News(10 mins):